Clover Health Investments Corp

Clover Health Investments Corp(CLOV)股票分析

$4.790

-0.020 (-0.42%)收盤時

Loading chart…
最高
4.890
開盤
4.760
成交量加權均價
4.80
成交量
3.75M
市值
645.37M
最低
4.730
成交金額
18.04M
企業價值/稅息折舊攤銷前利潤(TTM)
17.36

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.

AI 分析 of Clover Health Investments Corp (CLOV)

買進

Clover Health Investments Corp is a good buy right now due to its recent performance and positive market indicators. The current price is $4.79, and the stock has seen a year-to-date change of +98.76%, indicating strong momentum. Additionally, the RSI is at 71.449, suggesting that the stock is in a strong bullish trend. The forward P/E ratio is 37.7358, which, while high, reflects growth potential in the expanding Medicare Advantage market. The main risk is the high volatility indicated by an implied volatility of 85.65%, which could lead to significant price fluctuations.

估值指標

Clover Health Investments Corp(CLOV)目前預期本益比為 37.74,5 年平均預期本益比為 3.43。

預期本益比

合理
5 年均值 P/E
3.43
目前P/E
37.74
高估
40.64
低估
-33.78

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
10.95
目前EV/EBITDA
17.36
高估
30.05
低估
-8.15

預期股價營收比

合理
5 年均值 P/S
0.55
目前P/S
0.72
高估
0.88
低估
0.22

Alphio AI 對 CLOV 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CLOV

$3.66

情境價格

基

基準

基準 · 50%CLOV

$3.60

情境價格

悲

悲觀

悲觀 · 25%CLOV

$3.51

情境價格

持有 CLOV 的大戶

G

GMT Capital Corp.

+ 持有CLOV

+2.52%

3個月報酬率

事件時間軸

2026-10-08 (ET)

20:00:00

Nasdaq Composite Falls 1.3% as Tech Stocks Struggle

2026-09-10 (ET)

16:30:00

Major Averages Close Broadly Lower as Oil Surpasses $100

12:30:00

Major Averages Broadly Lower as Oil Surpasses $100

12:30:00

Clover Health Shares Rise 9.1% to $4.74

資訊

CLOV 常見問題 —— 由 Alphio AI 解答

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Clover Health Investments Corp is a good buy right now due to its recent performance and positive market indicators. The current price is $4.79, and the stock has seen a year-to-date change of +98.76%, indicating strong momentum. Additionally, the RSI is at 71.449, suggesting that the stock is in a strong bullish trend. The forward P/E ratio is 37.7358, which, while high, reflects growth potential in the expanding Medicare Advantage market. The main risk is the high volatility indicated by an implied volatility of 85.65%, which could lead to significant price fluctuations.

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易